Disclosed herein are compounds, pharmaceutical compositions, and methods for the treatment of viral infection, including RNA viral infection, as well as compounds, pharmaceutical compositions, and methods for modulating the RIG-I pathway in a subject and/or in cells. These compounds are isoflavone derivatives, typically substituted at the 3-position with an aryl group and at the 7-position with a heterofunctional group.
本文披露了化合物、制药组合物以及治疗病毒感染的方法,包括RNA病毒感染的方法,以及在受体内和/或细胞中调节RIG-I通路的化合物、制药组合物和方法。这些化合物是异
黄酮衍
生物,通常在3位上用芳基基团取代,在7位上用杂功能基团取代。